Law360, New York (May 11, 2015, 6:36 PM EDT) -- Hoffmann-La Roche Ltd. and plaintiffs in consolidated New Jersey litigation over claims the company's acne treatment Accutane caused bowel disease agreed Friday that roughly 2,000 cases in the litigation were foiled by a February ruling rejecting testimony by the plaintiffs' experts.
Judge Nelson Johnson signed off on an agreement Friday by the parties that his ruling thwarts those cases, resulting in those suits being dismissed with prejudice. Some 4,500 cases now remain in the litigation. The dismissed cases only include those in which the parties agreed that the plaintiff was clearly suffering from Crohn's disease.
There still remain pending suits in...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!